OLR1 and glioblastoma: As recently reviewed elsewhere [201], LOX1 may provide an excellent target to restore immune function in a broad range of patients with cancer, particularly those with glioblastoma (GBM) where LOX1+ PMN-MDSC was demonstrated to play a prominent role in driving cancer development [202].